Biote (BTMD) Equity Average (2021 - 2026)

Biote's Equity Average history runs 6 years deep, the most recent figure standing at -$53.2 million for Q1 2026.

• In Q1 2026, Equity Average rose 43.06% year-over-year to -$53.2 million; the TTM figure through Mar 2026 stood at -$53.2 million (up 43.06% YoY), while the FY2025 annual figure was -$80.4 million, down 15.85% from the prior year.
• Equity Average was -$53.2 million for Q1 2026 at Biote, up from -$62.0 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $7.4 million in Q1 2022 to a low of -$134.1 million in Q3 2024.
• Historically, Equity Average has averaged -$68.2 million across 5 years, with a median of -$71.0 million in 2023.
• Biggest YoY gain for Equity Average was 153.76% in 2022; the steepest drop was 4758.04% in 2022.
• A 5-year view of Equity Average shows it stood at -$64.6 million in 2022, then surged by 31.99% to -$43.9 million in 2023, then plunged by 160.81% to -$114.5 million in 2024, then surged by 45.85% to -$62.0 million in 2025, then rose by 14.12% to -$53.2 million in 2026.
• The last three Equity Average figures came in at -$53.2 million (Q1 2026), -$62.0 million (Q4 2025), and -$72.2 million (Q3 2025), per Business Quant data.